1 hour ago
Moderna (MRNA) Stock Surges 169% Despite Wall Street Skepticism
Moderna (MRNA) climbed to $81.42, up 169% annually. Analysts set average target at $37 while insiders sold $6.1M worth of shares in three months.
The post Moderna (MRNA) Stock Surges 169% Despite Wall Street Skepticism appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Market Highlights: Broadcom’s Apple Deal, SpaceX Nasdaq Entry, and TeraWulf’s AI...
- 1 hour ago
Arm Holdings (ARM) Stock Surges 5% Amid Semiconductor Sector Rebound
- 1 hour ago
Palo Alto Networks (PANW) Stock Surges to New Peak as AI Security Concerns Drive...
- 1 hour ago
GE Vernova (GEV) Stock Soars to Record High as Cramer Doubles Down on Position
- 2 hours ago
Rivian (RIVN) Stock Surges 6% Following Impressive Q2 Delivery Performance